.

Deeper Knowledge, Faster

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Fish and Richardson
Healthtrust
AstraZeneca
Daiichi Sankyo
Dow
Chinese Patent Office
Merck
Cipla
Cerilliant
Farmers Insurance

Generated: September 26, 2017

DrugPatentWatch Database Preview

Claims for Patent: ► Subscribe

« Back to Dashboard

Claims for Patent: ► Subscribe

Title: Phosphorus binder
Abstract:A composition for oral administration to an individual for the purpose of inhibiting gastrointestinal absorption of phosphorous, which includes calcium acetate. A method of inhibiting gastrointestinal absorption of phosphorous, comprising administering orally the composition, preferably close in time to food and beverage consumption.
Inventor(s): Fordtran; John S. (Dallas, TX)
Assignee: Braintree Laboratories, Inc. (Braintree, MA)
Application Number:07/035,341
Patent Claims: 1. A method for inhibiting gastrointestinal absorption of phosphorous in an individual, comprising:

orally ingesting a quantity of calcium acetate sufficient to bind with phosphorous in the gastrointestinal tract.

2. The method according to claim 1 wherein the calcium acetate is present in an amount sufficient to provide between 10 to 200 milliequivalents of calcium.

3. The method according to claim 1 wherein the calcium acetate is in tablet form.

4. The method according to claim 1 wherein the calcium acetate is in gelatin capsule form.

5. A method for inhibiting gastrointestinal absorption of phosphorous in an individual, comprising:

orally ingesting a quantity of calcium acetate at mealtimes.

6. The method according to claim 5 wherein the quantity of calcium acetate is present in an amount sufficient to produce between 10-200 milliequivalents of calcium.

7. The method according to claim 5 wherein the quantity of calcium acetate is in tablet form.

8. The method according to claim 5 wherein the quantity of calcium acetate is in gelatin capsule form.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Medtronic
Baxter
Covington
Daiichi Sankyo
Colorcon
QuintilesIMS
Cantor Fitzgerald
Chubb
Harvard Business School
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot